Yılmaz, N. K. (2026) “Dasatinib as a Repurposing Candidate for Alzheimer’s Disease: An Integrated In Silico Network Pharmacology and Molecular Docking Study”, Trends in Pharmacy, 3, pp. 1–11. doi: 10.5152/TIP.2026.26015.